Continuous Glucose Monitors to Regulate Glucose Levels in Type 2 Diabetics - (Protocol 3)

Completed · Not applicable

Conditions studied: Type2 Diabetes

In brief

This study allows Type 2 diabetics to receive feedback from a continuous glucose monitor (CGM) as part of an educational program designed to help them better manage their glucose levels. Subjects will also wear an activity tracker to monitor their activity and observe its effect on their glucose levels. The educational program will involve calls from coaches to check subjects' progress and answer questions.

Key facts

Study ID

NCT03290768

Run by

Savvysherpa, Inc.

People needed

358

Starts

2017-09-13

Expected to finish

2018-06-01

Last updated by the study team

2021-05-18

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Be diagnosed with type 2 diabetes
• Be able to read and understand English
• Have access to a telephone
• Have a Medicare Advantage health plan through Senior Dimensions

You may not qualify if…

• Pregnant
• Blind
• Deaf
• Receiving chemotherapy or radiation to treat cancer (now or in past 6 months)
• Misusing any drugs (including alcohol, painkillers, hallucinogens, or others)
• Critically ill
• Diagnosed with or experiencing:
• Kidney disease stages 4 and 5
• End stage renal disease
• Severe liver disease
• Dementia
• Schizophrenia
• Bipolar disorder
• Autism
• An intellectual or learning disability
• Arrhythmias other than atrial fibrillation
• Congestive heart failure
• Has had a:
• Myocardial infarction within the last 6 months
• Stroke within the last 6 months
• Stroke that resulted in significant disability (e.g., unable to write clearly or walk)

Where it is running

• Southwest Medical Associates — Las Vegas, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.